45.00
price down icon2.00%   -0.92
after-market  アフターアワーズ:  45.00 
loading

Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals (NASDAQ:CRBP) Lifted to "Hold" at StockNews.com - MarketBeat

pulisher
MarketBeat

Corbus Pharmaceuticals (NASDAQ:CRBP) Raised to Hold at StockNews.com - Defense World

pulisher
Defense World

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

pulisher
MarketWatch

Attention Biotech Investors - Stocks To Watch - Agios Pharmaceuticals (NASDAQ:AGIO), Corbus Pharmaceutica - Benzinga

pulisher
Benzinga

Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference - Corbus Pharmaceutic - Benzinga

pulisher
Benzinga

Where are the Opportunities in (CRBP) - Stock Traders Daily

pulisher
Stock Traders Daily

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

pulisher
MarketWatch

Royal Bank of Canada Initiates Coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) - Defense World

pulisher
Defense World

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

pulisher
MarketWatch

Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Wei - Benzinga

pulisher
Benzinga

Corbus Pharmaceuticals (NASDAQ:CRBP) Receives New Coverage from Analysts at Royal Bank of Canada - MarketBeat

pulisher
MarketBeat

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets - Seeking Alpha

pulisher
Seeking Alpha

StockNews.com Lowers Corbus Pharmaceuticals (NASDAQ:CRBP) to Sell - Defense World

pulisher
Defense World

Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint - Yahoo News UK

pulisher
Yahoo News UK

Oppenheimer Raises Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $60.00 - Defense World

pulisher
Defense World

Corbus Pharmaceuticals: 2Q Earnings Snapshot - Yahoo News UK

pulisher
Yahoo News UK

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 11% last week - Simply Wall St

pulisher
Simply Wall St

How Much Of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Do Insiders Own? - Yahoo Movies UK

pulisher
Yahoo Movies UK

Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference - Yahoo Finance

pulisher
Yahoo Finance

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer - MarketBeat

pulisher
MarketBeat

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer - MarketBeat

pulisher
MarketBeat

Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

pulisher
GlobeNewswire

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

pulisher
Yahoo Finance

Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK

pulisher
Yahoo Movies UK

Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3% - Yahoo Movies UK

pulisher
Yahoo Movies UK

Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint - Yahoo Singapore News

pulisher
Yahoo Singapore News

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum - GlobeNewswire

pulisher
GlobeNewswire

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum - Yahoo Finance

pulisher
Yahoo Finance

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

pulisher
GlobeNewswire Inc.

Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength

pulisher
Zacks Investment Research

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC - Yahoo Finance

pulisher
Yahoo Finance

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

pulisher
MarketWatch

What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'

pulisher
Zacks Investment Research

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Corbus Pharmaceuticals: Q4 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

pulisher
MarketWatch

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit - GlobeNewswire

pulisher
GlobeNewswire

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

pulisher
MarketWatch
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
大文字化:     |  ボリューム (24 時間):